3-Methylpyridine

3-Methylpyridine

SCHEMBL4298067

C(=C/c1ccccc1-c1ccccn1)\c1ccccc1.Cc1cccnc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.46
CYP11B1 P15538 1/20 0.46
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2A6 P11509 3/20 0.41
CYP19A1 P11511 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP1B1 Q16678 1/20 0.38
GRM4 Q14833 2/20 0.38
KDM1A O60341 3/20 0.37
KDM4E B2RXH2 1/20 0.36
ALOX5 P09917 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
FGF23 Q9GZV9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylpyridine SCHEMBL4298073 1.00 CYP11B2 (0.46) CYP11B2CYP11B1MEN1NPC1RAB9A
SCHEMBL2773355 0.85 KDM1A (0.47) CYP11B2CYP11B1NPC1RAB9ACYP1A2
SCHEMBL4155559 0.85 KDM1A (0.47) CYP11B2CYP11B1NPC1RAB9ACYP1A2
SCHEMBL28957625 0.78 CYP11B1 (0.49) CYP11B2CYP11B1MEN1NPC1RAB9A
SCHEMBL4159032 0.77 ALDH1A1 (0.47) NPC1RAB9AKMT2AGRM4KDM1A
SCHEMBL4159031 0.77 ALDH1A1 (0.47) NPC1RAB9AKMT2AGRM4KDM1A
SCHEMBL28565356 0.76 KDM1A (0.48) CYP11B2CYP11B1NPC1RAB9ACYP1A2
3-Methylpyridine SCHEMBL27675396 0.73 CYP11B2 (0.58) CYP11B2CYP11B1MEN1NPC1RAB9A
SCHEMBL8223992 0.71 KDM4E (0.45) CYP11B2CYP11B1MEN1NPC1RAB9A
SCHEMBL8223994 0.71 KDM4E (0.45) CYP11B2CYP11B1MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8212048-B2 Method of producing aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-03 US disclosed
US-20090043096-A1 METHOD OF PRODUCING AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090043096-A1 METHOD OF PRODUCING AROMATIC COMPOUND AHR, CYP1A1, ARNT CYP11B2 7/4885CYP11B1 13/4885MEN1 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.